Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferation

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 112

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_NAMJ-10-4_004

تاریخ نمایه سازی: 17 مهر 1402

چکیده مقاله:

Objective(s): Herbal compounds with cytotoxicity have been of great interest in recent years to improve cancer treatment methods. Fisetin is an anti-cancer herbal compound with low solubility in aqueous systems. Metformin is another compound with anti-cancer effects. In this study, the combined effect of fisetin and metformin was investigated using mesoporous silica nanoparticles (MSNs) in breast cancer cell lines. Materials and Methods: After the synthesis of nanoparticles, they were characterized using XRD, TEM, SEM. The DLS test showed a size of ۱۴۳.۴ nm with zeta-potential -۳۹.۱ mV. Fisetin and metformin were loaded into nanoparticles and loading was confirmed by FTIR. The toxicity of different concentrations of free drug (metformin, fisetin, fisetin-metformin) and Nanoformulations (metformin, fisetin and nano-fisetin-metformin) was investigated on two breast cancer lines MCF۷ and MDA-MB-۲۳۱. Results: Fisetin-metformin co-loaded in MSNs showed the highest cytotoxicity among all formulations in both cell lines. The inhibition of colony formation and migration rate was effectively observed in the co-treatment of cells with fisetin and metformin loaded in nanoparticles compared to single treatments. The expression of tumor suppressor miR-۲۰۰b-۳p and miR-۳۴a-۵p showed that fisetin increased the expression of these tumor suppressors compared to the control. Conclusion: The anti-cancer effect of fisetin-metformin in combination increased the expression of tumor suppressors due to the regulation of a wide range of gene network involving in cancer progress. The obtained results highlight the use of MSN as an effective drug delivery system for simultaneous delivery of herbal cytotoxic compounds in cancer.

نویسندگان

Mohammad Reza Karimzadeh

Department of Medical Genetics, School of Medicine, Bam University of Medical Sciences, Bam, Iran

Mahshid Samie Ghahfarokhi

Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran

Razieh Heidari

Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran

Somayeh Reiisi

Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Wang Y, Zhang T, Kwiatkowski N, Abraham BJ, Lee TI, ...
  • Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, ...
  • Liu W, Zhu Y, Wang F, Li X, Liu X, ...
  • Soheili N, Eshghi M, Emadi-Baygi M, Mirzaei SA, Heidari R, ...
  • Azadmehr A, Hajiaghaee R, Afshari A, Amirghofran Z, Refieian-Kopaei M, ...
  • Qi F, Li A, Inagaki Y, Gao J, Li J, ...
  • Hu C-MJ, Zhang L. Nanoparticle-based combination therapy toward overcoming drug ...
  • LoRusso PM, Canetta R, Wagner JA, Balogh EP, Nass SJ, ...
  • Li X, Takashima M, Yuba E, Harada A, Kono K. ...
  • Kim J, Kim J, Jeong C, Kim WJ. Synergistic nanomedicine ...
  • Khan N, Syed DN, Ahmad N, Mukhtar H. Fisetin: a ...
  • Bhat TA, Nambiar D, Pal A, Agarwal R, Singh RP. ...
  • Li J, Cheng Y, Qu W, Sun Y, Wang Z, ...
  • Khan MI, Adhami VM, Lall RK, Sechi M, Joshi DC, ...
  • Syed DN, Chamcheu J-C, Khan MI, Sechi M, Lall RK, ...
  • Maurya BK, Trigun SK. Fisetin attenuates AKT associated growth promoting ...
  • Khan N, Afaq F, Khusro FH, Mustafa Adhami V, Suh ...
  • Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin selectively ...
  • Ugwueze CV, Ogamba OJ, Young EE, Onyenekwe BM, Ezeokpo BC. ...
  • Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, ...
  • Dadwal A, Baldi A, Kumar Narang R. Nanoparticles as carriers ...
  • Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, ...
  • Liu X, Situ A, Kang Y, Villabroza KR, Liao Y, ...
  • Castillo RR, Colilla M, Vallet-Regí M. Advances in mesoporous silica-based ...
  • Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF. ...
  • Kashyap D, Garg VK, Tuli HS, Yerer MB, Sak K, ...
  • Imran M, Saeed F, Gilani SA, Shariati MA, Imran A, ...
  • Cui M, Wang H, Yao X, Zhang D, Xie Y, ...
  • Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song ...
  • Wu S-H, Mou C-Y, Lin H-P. Synthesis of mesoporous silica ...
  • Shi Y, Wan A, Shi Y, Zhang Y, Chen Y. ...
  • Thanki K, Gangwal RP, Sangamwar AT, Jain S. Oral delivery ...
  • Mohammed MA, Syeda J, Wasan KM, Wasan EK. An overview ...
  • Kang X, Chen H, Li S, Jie L, Hu J, ...
  • Falah RR, Talib WH, Shbailat SJ. Combination of metformin and ...
  • Farajzadeh R, Pilehvar-Soltanahmadi Y, Dadashpour M, Javidfar S, Lotfi-Attari J, ...
  • Zheng Z, Zhu W, Yang B, Chai R, Liu T, ...
  • Rasouli S, Zarghami N. Synergistic growth inhibitory effects of chrysin ...
  • Mdkhana B, Zaher DM, Abdin SM, Omar HA. Tangeretin boosts ...
  • Watermann A, Brieger J. Mesoporous silica nanoparticles as drug delivery ...
  • Saini K, Prabhuraj R, Bandyopadhyaya R. Development of mesoporous silica ...
  • Zheng Q, Cui X, Zhang D, Yang Y, Yan X, ...
  • Li L, Yuan L, Luo J, Gao J, Guo J, ...
  • Hong H, Yu H, Yuan J, Guo C, Cao H, ...
  • Hermeking H. The miR-۳۴ family in cancer and apoptosis. Cell ...
  • نمایش کامل مراجع